24 results match your criteria: "The WHO Collaborating Centre for Oral Cancer[Affiliation]"
Head Neck
January 2025
Faculty of Dental, Oral & Craniofacial Sciences, King's College London, and the WHO Collaborating Centre for Oral Cancer, London, UK.
Oral epithelial dysplasia (OED) is the primary histological marker for assessing the progression of oral potentially malignant disorders (OPMDs) to cancer. Despite challenges in grading and low inter-pathologist reproducibility, OED severity remains the key predictor of malignant transformation. However, globally accepted guidelines for OED monitoring are lacking, despite calls for individualized management based on host and lesion characteristics.
View Article and Find Full Text PDFOral Dis
August 2024
Oral Diagnosis Department, Piracicaba Dental School, State University of Campinas, Piracicaba, Brazil.
Oral Dis
October 2024
Piracicaba Dental School, University of Campinas, Piracicaba, São Paulo, Brazil.
Objective: This study aimed to explore perceived barriers to early diagnosis and management of oral cancer, as well as potential pathways for improvement in Latin America and the Caribbean (LAC).
Methods: This cross-sectional study used a self-administered online questionnaire created via the Research Electronic Data Capture platform. The survey was distributed to health professionals trained in Oral Medicine, Oral Pathology, Oral and Maxillofacial Surgery, and Dentists with clinical and academic expertise in oral potentially malignant disorder (OPMD) and oral cancer.
Lancet
November 2023
Department of Dental Surgery, Université Paul Sabatier, Centre Hospitalier Universitaire, Laboratoire Centre d'Anthropobiologie et de Génomique de Toulouse, Toulouse, France. Electronic address:
Oral Surg Oral Med Oral Pathol Oral Radiol
February 2024
Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, SP, Brazil. Electronic address:
Objective: This systematic review aimed to describe the method followed during physical examination and the anatomical structures of the head and neck assessed in screening for oral cancer and oral potentially malignant disorders (OPMDs).
Study Design: An extensive literature search was carried out using MEDLINE/PubMed, EMBASE, Scopus, LILACS, Web of Science, Cochrane databases, and gray literature. The risk of bias was available in all papers included.
Community Dent Oral Epidemiol
August 2023
School of Dentistry and Oral Health, Menzies Health Institute Queensland, Griffith University, Griffith, Queensland, Australia.
Objectives: Over the past several decades, oral cancer has been the most common malignancy among Sri Lankan males and the top 10 cancer among females, disproportionately affecting low socio-economic groups. Sri Lanka is a lower-middle-income developing country (LMIC), currently striking through an economic crisis, and social and political unrest. Occurring at an accessible body site and predominantly attributed to potentially modifiable health-related behaviours, oral cancer should be preventable and controllable.
View Article and Find Full Text PDFOral Surg Oral Med Oral Pathol Oral Radiol
September 2023
Oral Diagnosis Department, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, São Paulo, Brazil. Electronic address:
Objectives: To determine the prevalence of smokeless tobacco (SLT) use and its association with oral potentially malignant disorders (OPMDs) and head and neck cancer (HNC) in the Pan-American Health Organization (PAHO) region.
Study Design: A literature search was conducted across 9 databases and other sources. The eligibility criteria were pediatric (0-18 years old) and adult (19 years and older) populations consuming any type of SLT.
Oral Dis
November 2023
Dipartimento di Scienze Biomediche, Chirurgiche e odontoiatriche, Università degli Studi di Milano, Milano, Italy.
Oral Surg Oral Med Oral Pathol Oral Radiol
November 2022
Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, the WHO Collaborating Centre for Oral Cancer, London, United Kingdom.
Objectives: The objective of this study was to evaluate the expression of several cell membrane markers in oral squamous cell carcinomas (OSCC) and to examine their prognostic influence.
Study Design: We analyzed the immunohistochemical expression of claudin-1 (CLDN-1), claudin-4 (CLDN-4), claudin-5 (CLDN-5), claudin-7 (CLDN-7), occludin (OCLN), and E-cadherin (CDHE) in 60 patients with OSCC treated in a central hospital Center of Oporto. The prognostic significance of these biomarkers in cancer-specific survival and recurrence-free survival were evaluated using multivariate analysis.
Oral Dis
March 2024
Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, and the WHO Collaborating Centre for Oral Cancer, London, UK.
Objectives: The aim of this study is to identify and analyze the existing literature on the utility of podoplanin to predict the risk of malignancy development (MD) in patients previously diagnosed with oral leukoplakia (OL).
Methods: A systematic review and meta-analysis (SRMA) was performed though a search strategy using several electronic databases and a combination of keywords related to podoplanin and MD of OL, until 15 May, 2022 (PROSPERO CRD42022329326). Evaluation of the risk of bias (ROB) was performed using the Quality in Prognosis Studies Tool.
J Oral Pathol Med
September 2022
Department of Maxillofacial Surgery, School of Dentistry, Aichi Gakuin University, Nagoya, Japan.
Background: Polymorphous adenocarcinoma is a common intraoral minor salivary gland carcinoma in Western countries but is extremely rare in Japan. The current study aimed to characterize the clinicopathological features and status of molecular alterations of polymorphous adenocarcinoma-associated genes, such as PRKD1/2/3, ARID1A, and DDX3X, in a large cohort of Japanese patients with polymorphous adenocarcinoma.
Methods: We examined the cases of 36 Japanese patients with salivary gland polymorphous adenocarcinoma and 26 cases involving histopathological mimics.
Biomolecules
April 2022
Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, The WHO Collaborating Centre for Oral Cancer, London SE1 9RT, UK.
Our aim was to evaluate the expression of biomarkers, CD44v6, CD147, EGFR, p53, p63, p73, p16, and podoplanin in oral leukoplakias (OL) and to assess their potential for prediction of malignant transformation (MT). We analyzed the expression of CD44v6, CD147, EGFR, p53, p63, p73, p16, and podoplanin by immunohistochemistry in 52 OL, comprised of 41 low-grade (LG) dysplasia and 11 high-grade (HG) cases. Twelve healthy normal tissues (NT) were also included.
View Article and Find Full Text PDFOral Oncol
July 2022
Faculté de Chirurgie Dentaire, Université Paul Sabatier, Centre Hospitalier Universitaire, Toulouse, France; Laboratoire Centre d'Anthropobiologie et de Génomique de Toulouse, Université Paul Sabatier, Toulouse, France. Electronic address:
J Dent Res
September 2022
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei.
Areca nut chewing is one of the major risk factors for oral cancer, with large-magnitude risks reported in studies comparing betel quid chewers and never users, and it has been evaluated as a group 1 carcinogen by the International Agency for Research on Cancer. Data from a high-quality meta-analysis examining risk estimates are presented in summary form with additional information from more recent studies (pooled adjusted relative risk, 7.9; 95% CI, 7.
View Article and Find Full Text PDFOral Dis
November 2021
School of Dental Sciences, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
Histopathological grading of epithelial dysplasia remains the principal laboratory method for assessing the risk of malignant transformation in oral potentially malignant disorders (OPMDs). Current views on the molecular pathogenesis and histological interpretation of the features of epithelial dysplasia are described, and the use of grading systems for epithelial dysplasia is discussed. Changes to the current 2017 WHO criteria for diagnosis are proposed with emphasis on the architectural features of epithelial dysplasia.
View Article and Find Full Text PDFOral Dis
November 2021
Dipartimento di Scienze Biomediche, Chirurgiche e Odontoiatriche, Università degli Studi di Milano, Milano, Italia.
Oral Oncol
July 2021
Département de Médecine Orale, Institut Claudius Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, 1, avenue Irène Joliot Curie, 31059 Toulouse cedex 9, France.
Oral Dis
November 2021
Faculty of Dentistry, Oral and Craniofacial Sciences, King's College London, and the WHO Collaborating Centre for Oral Cancer, London, UK.
Objectives: This systematic review and meta-analysis aimed to determine the proportion of patients who develop oral carcinomas following a diagnosis of oral submucous fibrosis (OSF) in reported longitudinal studies. We also aimed to evaluate the demographic and clinicopathological factors contributing to the progression of OSF to cancer.
Methods: Individual search strategies were applied for the following bibliographic databases: MEDLINE by PubMed, Scopus, Embase, Web of Science, and Grey literature databases until August 30, 2020.
Oral Dis
November 2021
Menzies Health Institute Queensland and School of Dentistry and Oral Health, Griffith University, Gold Coast, Qld, Australia.
Oral potentially malignant disorders (OPMDs) are associated with an increased risk of occurrence of cancers of the lip or oral cavity. This paper presents an updated report on the nomenclature and the classification of OPMDs, based predominantly on their clinical features, following discussions by an expert group at a workshop held by the World Health Organization (WHO) Collaborating Centre for Oral Cancer in the UK. The first workshop held in London in 2005 considered a wide spectrum of disorders under the term "potentially malignant disorders of the oral mucosa" (PMD) (now referred to as oral potentially malignant disorders: OPMD) including leukoplakia, erythroplakia, proliferative verrucous leukoplakia, oral lichen planus, oral submucous fibrosis, palatal lesions in reverse smokers, lupus erythematosus, epidermolysis bullosa, and dyskeratosis congenita.
View Article and Find Full Text PDFAnal Cell Pathol (Amst)
October 2018
Pathology Department, School of Medicine-University Clinical Hospital, University of Santiago de Compostela, CP 15706 Santiago, Spain.
We analysed the expression of cyclins A2, B1, D1, and E1 by immunohistochemistry and numerical aberrations in gene by fluorescence in situ hybridization technique in 67 primary oral squamous cell carcinomas (OSCC). Cyclin A2 expression was observed in 54 (83.1%) tumours, cyclin D1 in 58 (89.
View Article and Find Full Text PDFJ Oral Pathol Med
April 2018
Pathology, School of Medicine - University Clinical Hospital, University of Santiago de Compostela, Santiago de Compostela, Spain.
Background: Oral cancer is a major public health problem worldwide, with a poor survival. Our aim was to evaluate several protein markers in oral squamous cell carcinomas (OSCC) and analyse their prognostic value on patient's survival.
Methods: We analysed the expression of EGFR, p53, p27, p16, cyclin D1, cyclin A2, COX-2, Ki-67, Bcl-2, VEGFR-1 and VEGFR-2, by immunohistochemistry on 67 primary OSCC.
Oral Surg Oral Med Oral Pathol Oral Radiol
August 2016
Department of Oral Medicine, King's College, London, United Kingdom; and the WHO Collaborating Centre for Oral Cancer, London, United Kingdom. Electronic address:
Oral submucous fibrosis (OSF) is a chronic, insidious disease characterized by progressive submucosal fibrosis of the oral cavity and the oropharynx. People affected by this disease mostly live in south Asia, but migrants from these countries to the United States and Europe may present with OSF. We provide a historical background of the disease, and the objective of this review is to update the current knowledge on the etiology and etiopathogenesis of OSF.
View Article and Find Full Text PDFOral Dis
May 2016
Oral Medicine, The WHO Collaborating Centre for Oral Cancer, King's College, London, UK.
Objectives: To analyse the expression of the CD44v6, p63, podoplanin and MMP-9, and their prognostic significance in patients with oral squamous cell carcinomas (OSCC).
Material And Methods: Immunohistochemistry technique was performed on 60 OSCC for detection of CD44v6, p63, podoplanin and MMP-9 proteins. Extent and intensity of staining were evaluated in tumour cells and were compared with patients' clinical-pathological characteristics and survival.
J Oral Pathol Med
October 2011
Department of Clinical & Diagnostic Sciences, Oral Medicine, King's College London Dental Institute and the WHO Collaborating Centre for Oral Cancer and Precancer, London, UK.
Objective: The aims of the study were to determine how frequently oral potentially malignant disorders (OPMDs) transform to cancer and to identify clinical and histological factors determining the rates of transformation.
Methods: The study included 1357 patients with biopsy-confirmed OPMDs seen at Guy's Hospital between 1990 and 1999 and followed up until 2005. The patients' details (name, date of birth, gender and any other relevant information) were matched to the Thames Cancer Registry (TCR) database and Office for National Statistics (ONS) to identify patients who subsequently developed oral cancer (ICD-10 C00-C06).